The global facial injectable market size was worth USD 14.5 billion in 2021. It is expected to reach USD 31 billion by 2030, growing at a CAGR of 8.8% during the forecast period (2022–2030). A large population susceptible to various signs of aging is boosting the demand for facial injectable medicine globally.

New York, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Increasing awareness about esthetic procedures among consumers and the growing geriatric population worldwide are anticipated to drive the market. Furthermore, the shift in trend from invasive to minimally invasive procedures and advancements in facial rejuvenation is expected to support market growth over the forecast period. Advances in facial rejuvenation procedures with changes in products, practices, and patient demographics are helping dermatologists or physicians treat multiple facial areas & customize treatments for individual patients, and facilitate the use of a combination of products to obtain better outcomes. These factors propelled the market growth over the forecast period.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/facial-injectable-market/request-sample

Shifting Consumer Preference for Minimally Invasive Procedures Drive the Global Facial Injectable Market

A shift from invasive to minimally invasive procedures is expected to fuel the market growth over the forecast period. According to ISAPS, 13,618,735 noninvasive procedures were performed globally in 2019, out of which 3,982,749 were performed in the US. More people are opting for permanent methods such as fillers, fat grafting, and lip advancement. The most popular procedures are fillers, as the risk associated with this treatment is very low. Fillers such as hyaluronic acid and poly-L lactic acid are readily accepted by the body, leading to minimal side effects and allergic reactions. ISAPS also suggests that botulinum toxin filler, hyaluronic acid filler, non-surgical fat reduction, and photo rejuvenation are some standard, in-demand, noninvasive esthetic procedures.

Minimally invasive procedures offer fewer incisions, shorter hospital stays, quick outpatient services, rapid wound healing, lesser pain, and a lower risk of complications than invasive surgeries. Therefore, the demand for facial injectables will increase during the forecast period. Moreover, many dermatologists believe that COVID-19 may act as a springboard to improving patient footfall post-pandemic drastically. According to a survey of 1,000 American women in 2020 by the American Society of Plastic Surgeons, 11% of participants indicated that they are more inclined to opt for minimally invasive post-pandemic procedures than before COVID-19. Even during the pandemic, Botox and soft tissue fillers remained the most popular minimally invasive procedure in the US.

Growing Population Aged 25–65 Years Create Tremendous Opportunities for Facial Injectable

Wrinkles and sagging skin from lack of face elasticity, dark spots, and other aging symptoms start to show up between the ages of 25 and 30, and they grow more evident between the ages of 30 and 65. Therefore, a large population susceptible to various signs of aging is boosting the demand for facial injectable medicine globally. According to World Population Prospects 2019, in 2050, one out of six people will be aged 65 globally, increasing from one in 11 in 2019. According to the estimates published by United Nations, there were 703 million people above the age of 65 around the world in 2019, and the number of older adults is estimated to double by 2050.

According to the United Nations Population Fund (UNFPA) State of World Population 2019, released in April 2020, India's population in 2019 was 1.36 billion, increasing from 942.2 million in 1994, and 6% of India's population was aged 65 and above. Between 2019 and 2050, nine out of the ten countries with the most significant percentage point increase in the share of elderly persons are estimated to be in Eastern and Southeastern Asia. Consequently, the population prone to experiencing signs of aging is expected to grow during the forecast period.

Report Scope

Report Metric	Details
Market Size by 2030	USD 31 billion
Market Size in 2021	USD 14.5 billion
CAGR	8.8% (2022-2030)
Historical Data	2019-2020
Base Year	2021
Forecast Period	2022-2030
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Product, By Application
Geographies Covered	North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors	Allergan, Galderma, Merz Pharma Gmbh, Ipsen Pharma, Suneva Medical, Inc., Medytox, Sinclair Pharma, Bloomage Biotechnology Corporation Limited, and Anika Therapeutics Inc.
Key Market Opportunities	Growing Population Aged 25–65 Years
Key Market Drivers	Increasing Beauty Consciousness Among People

Buy Now Full Report @ https://straitsresearch.com/buy-now/facial-injectable-market

Regional Insights

North America held over 41% share in the global facial injectable market in 2021 due to increased spending on aesthetic procedures. It is expected to grow at a CAGR of 9.18% during the forecast period. A large geriatric population base in the US and Canada is anticipated to propel the demand for injectables over the forecast period. 

Asia-Pacific is anticipated to be the fastest-growing region over the forecast period. China, India, and Japan are the developing economies in this region and have great potential for growth in the facial injectable market. This can be attributed to the growing medical tourism industry, especially in these countries. A large number of surgical procedures performed in South Korea, Japan, and China each year are primarily driving the market growth in this region. Many esthetic procedures can be attributed to the easy availability of advanced techniques and cost-effective treatment options. Additionally, a large geriatric population is anticipated to be a high-impact rendering driver for this region. 

Europe is the second-largest region and is expected to grow at a CAGR of 8.6% during the forecast period. Germany is one of the significant countries spearheading the facial injectable market. Factors such as the increased popularity of cosmetic procedures, technological advancements, and beauty consciousness are among the factors driving the market growth. Furthermore, the rising urban population, novel product approvals, promotions in noninvasive procedures, and availability of skilled professionals are other factors leading to the market growth.

Key Highlights

• The global facial injectable market size is expected to reach USD 31 billion by 2030, growing at a CAGR of 8.8% during the forecast period (2022–2030).
• Based on product, the global facial injectable market is segmented into Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, and Polymer Fillers. Botulinum Toxin Type A dominates the market and is expected to grow at a CAGR of 9.2% during the forecast period.
• Based on application, the global facial injectable market is segmented into Aesthetics and Therapeutics. The Aesthetics segment is expected to grow at a CAGR of 9.25% during the forecast period.
• Based on region, the global facial injectable market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to grow at a CAGR of 9.18% during the forecast period.

Competitive Players

The key players in the market are Allergan, Galderma, Merz Pharma Gmbh, Ipsen Pharma, Suneva Medical, Inc., Medytox, Sinclair Pharma, Bloomage Biotechnology Corporation Limited, and Anika Therapeutics, Inc.

Global Facial Injectable Market: Segmentation

 By Product

• Collagen
• Hyaluronic Acid
• Botulinum Toxin Type A
• Calcium Hydroxylapatite
• Polymer Fillers

 By Application

• Aesthetics
• Therapeutics

 By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

TABLE OF CONTENT

1. EXECUTIVE SUMMARY
2. RESEARCH SCOPE & SEGMENTATION
   1. Research Objectives
   2. Market Definition
   3. Limitations & Assumptions
   4. Market Scope & Segmentation
   5. Currency & Pricing Considered
3. MARKET OPPORTUNITY ASSESSMENT

3. 1. Emerging Regions / Countries
   2. Emerging Companies
   3. Emerging Applications / End Use
   4. Investment Landscape
   5. New Business Models / Revenue Streams
   6. TAM

4. MARKET TRENDS

4. 1. Drivers
   2. Market Warning Factors
   3. Latest Macro Economic Indicators
   4. Geopolitical Impact
   5. Human Factors
   6. Technology Factors

5. MARKET ASSESSMENT

5. 1. Porters Five Forces Analysis
   2. Value Chain Analysis
   3. Sales And Distribution Channel Analysis
   4. Trade Analysis
   5. Average Pricing Analysis
   6. Patent Analysis
   7. M & A Agreements & Collabration Analysis
   8. Cost Structure Analysis

6. ESG TRENDS
7. GLOBAL FACIAL INJECTABLE MARKET SIZE ANALYSIS

7. 1. Global Facial Injectable Market Introduction
   2. By Product

7. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

7. 2. 2. Collagen

1. 1. 1. 1. By Value

7. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

7. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

7. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

7. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

7. 3. By Application

7. 3. 1. Introduction

1. 1. 1. 1. Application By Value

7. 3. 2. Aesthetics

1. 1. 1. 1. By Value

7. 3. 3. Therapeutics

1. 1. 1. 1. By Value

8. NORTH AMERICA MARKET ANALYSIS

8. 1. Introduction
   2. By Product

8. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

8. 2. 2. Collagen

1. 1. 1. 1. By Value

8. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

8. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

8. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

8. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

8. 3. By Application

8. 3. 1. Introduction

1. 1. 1. 1. Application By Value

8. 3. 2. Aesthetics

1. 1. 1. 1. By Value

8. 3. 3. Therapeutics

1. 1. 1. 1. By Value

8. 4. U.S.

8. 4. 1. By Product

1. 1. 1. 1. Introduction
            1. By Product By Value
         2. Collagen
            1. By Value
         3. Hyaluronic Acid
            1. By Value
         4. Botulinum Toxin Type A
            1. By Value
         5. Calcium Hydroxylapatite
            1. By Value
         6. Polymer Fillers
            1. By Value

8. 4. 2. By Application

1. 1. 1. 1. Introduction
            1. Application By Value
         2. Aesthetics
            1. By Value
         3. Therapeutics
            1. By Value

8. 5. Canada

9. EUROPE MARKET ANALYSIS

9. 1. Introduction
   2. By Product

9. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

9. 2. 2. Collagen

1. 1. 1. 1. By Value

9. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

9. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

9. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

9. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

9. 3. By Application
      1. Introduction

1. 1. 1. 1. Application By Value

9. 3. 2. Aesthetics

1. 1. 1. 1. By Value

9. 3. 3. Therapeutics

1. 1. 1. 1. By Value

9. 4. U.K.

9. 4. 1. By Product

1. 1. 1. 1. Introduction
            1. By Product By Value
         2. Collagen
            1. By Value
         3. Hyaluronic Acid
            1. By Value
         4. Botulinum Toxin Type A
            1. By Value
         5. Calcium Hydroxylapatite
            1. By Value
         6. Polymer Fillers
            1. By Value

9. 4. 2. By Application

1. 1. 1. 1. Introduction
            1. Application By Value
         2. Aesthetics
            1. By Value
         3. Therapeutics
            1. By Value

9. 5. Germany
   6. France
   7. Spain
   8. Italy
   9. Russia
   10. Nordic
   11. Benelux
   12. Rest Of Europe

10. APAC MARKET ANALYSIS

10. 1. Introduction
    2. By Product

10. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

10. 2. 2. Collagen

1. 1. 1. 1. By Value

10. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

10. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

10. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

10. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

10. 3. By Application

10. 3. 1. Introduction

1. 1. 1. 1. Application By Value

10. 3. 2. Aesthetics

1. 1. 1. 1. By Value

10. 3. 3. Therapeutics

1. 1. 1. 1. By Value

10. 4. China

10. 4. 1. By Product

1. 1. 1. 1. Introduction
            1. By Product By Value
         2. Collagen
            1. By Value
         3. Hyaluronic Acid
            1. By Value
         4. Botulinum Toxin Type A
            1. By Value
         5. Calcium Hydroxylapatite
            1. By Value
         6. Polymer Fillers
            1. By Value

10. 4. 2. By Application

1. 1. 1. 1. Introduction
            1. Application By Value
         2. Aesthetics
            1. By Value
         3. Therapeutics
            1. By Value

10. 5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest Of Asia-Pacific

11. MIDDLE EAST AND AFRICA MARKET ANALYSIS

11. 1. Introduction
    2. By Product

11. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

11. 2. 2. Collagen

1. 1. 1. 1. By Value

11. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

11. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

11. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

11. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

11. 3. By Application

11. 3. 1. Introduction

1. 1. 1. 1. Application By Value

11. 3. 2. Aesthetics

1. 1. 1. 1. By Value

11. 3. 3. Therapeutics

1. 1. 1. 1. By Value

11. 4. UAE

11. 4. 1. By Product

1. 1. 1. 1. Introduction
            1. By Product By Value
         2. Collagen
            1. By Value
         3. Hyaluronic Acid
            1. By Value
         4. Botulinum Toxin Type A
            1. By Value
         5. Calcium Hydroxylapatite
            1. By Value
         6. Polymer Fillers
            1. By Value

11. 4. 2. By Application

1. 1. 1. 1. Introduction
            1. Application By Value
         2. Aesthetics
            1. By Value
         3. Therapeutics
            1. By Value

11. 5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest Of MEA

12. LATAM MARKET ANALYSIS

12. 1. Introduction
    2. By Product

12. 2. 1. Introduction

1. 1. 1. 1. By Product By Value

12. 2. 2. Collagen

1. 1. 1. 1. By Value

12. 2. 3. Hyaluronic Acid

1. 1. 1. 1. By Value

12. 2. 4. Botulinum Toxin Type A

1. 1. 1. 1. By Value

12. 2. 5. Calcium Hydroxylapatite

1. 1. 1. 1. By Value

12. 2. 6. Polymer Fillers

1. 1. 1. 1. By Value

12. 3. By Application

12. 3. 1. Introduction

1. 1. 1. 1. Application By Value

12. 3. 2. Aesthetics

1. 1. 1. 1. By Value

12. 3. 3. Therapeutics

1. 1. 1. 1. By Value

12. 4. Brazil

12. 4. 1. By Product

1. 1. 1. 1. Introduction
            1. By Product By Value
         2. Collagen
            1. By Value
         3. Hyaluronic Acid
            1. By Value
         4. Botulinum Toxin Type A
            1. By Value
         5. Calcium Hydroxylapatite
            1. By Value
         6. Polymer Fillers
            1. By Value

12. 4. 2. By Application

1. 1. 1. 1. Introduction
            1. Application By Value
         2. Aesthetics
            1. By Value
         3. Therapeutics
            1. By Value

12. 5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest Of LATAM

13. COMPETITIVE ASSESSMENT

13. 1. Adoption Matrix
    2. Facial Injectable Market Share By Manufacturers
    3. Facial Injectable Market Ranking By Revenue For Manufacturers
    4. Average Price By Manufacturers
    5. Vendor Footprint Analysis

14. MARKET PLAYERS ASSESSMENT

14. 1. Allergan

14. 1. 1. Overview
       2. Business Information
       3. Revenue
       4. ASP
       5. Gross Margin
       6. Swot Analysis
       7. Recent Developmments

14. 2. Galderma
    3. Merz Pharma Gmbh
    4. Ipsen Pharma
    5. Suneva Medical, Inc
    6. Medytox
    7. Sinclair Pharma
    8. Bloomage Biotechnology Corporation Limited
    9. Anika Therapeutics, Inc

15. RESEARCH METHODOLOGY

15. 1. Research Data

15. 1. 1. Secondary Data

1. 1. 1. 1. Major Secondary Sources
         2. Key Data From Secondary Sources

15. 1. 2. Primary Data

1. 1. 1. 1. Key Data From Primary Sources
         2. Breakdown Of Primaries

15. 1. 3. Secondary And Primary Research

1. 1. 1. 1. Key Industry Insights

15. 2. Market Size Estimation

15. 2. 1. Bottom-Up Approach
       2. Top-Down Approach
       3. Market Projection

15. 3. Research Assumptions

15. 3. 1. Assumptions

15. 4. Limitations
    5. Risk Assessment

16. APPENDIX

16. 1. Discussion Guide
    2. Customization Options
    3. Related Reports

17. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/facial-injectable-market/toc

Market News

• In June 2022, Ipsen received a positive opinion in Europe for Dysport® in managing urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury. 
• In May 2022, ASCO 2022: New Cabometyx® data show encouraging results in monotherapy and combination across different tumor types, including metastatic non-small cell lung cancer. 
• In May 2022, European Commission approved Cabometyx® as a second-line treatment for people living with radioactive iodine refractory differentiated thyroid cancer. 

News Media

Global Needle-Free Injection Systems Market to Grow at a CAGR of 16%

Rise in Dehydration Incidences to Spur Multiple Electrolytes Injection Market Healthy Growth

Have a Look at the Related Research Report

Dermatology Excimer Laser Market: Information by Product (Table top Excimer Lasers, Hand-held Excimer Lasers), Application (Psoriasis, Vitiligo), and Region- Forecast till 2030

Dermatological Drugs Market: Information by Dermatological Diseases (Acne, Dermatitis), Prescription Mode (Prescription Based Drugs, Over Counter Drugs), and Region — Forecast till 2030

Dermatological Therapeutics Market: Information by Drug Class (Corticosteroids, Anti-Acne, Retinoids), Application (Alopecia, Herpes, Psoriasis), and Region — Forecast till 2029

About Straits Research Pvt. Ltd.      

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (the U.S.)

+91 8087085354 (APAC)     

+44 203 695 0070 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.